imiquimod has been researched along with lipid a in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daugimont, L; Lecouturier, N; Préat, V; Richiardi, H; Ucakar, B; Vanderhaeghen, ML; Vandermeulen, G | 1 |
| Boyd, BJ; Hanley, T; Hook, S; McBurney, WT; Rades, T; Rizwan, SB; Young, K | 1 |
| Kim, S; Lim, YT; Noh, HJ; Noh, YW; Shin, WJ; Um, SH | 1 |
| Emami, T; Habibi, G; Hojatizade, M; Jaafari, MR; Khamesipour, A; Madani, R; Rezayat, SM | 1 |
| Burton, SA; Chu, LY; Hansen, KJ; Niu, L; Panyam, J | 1 |
| Fan, F; Huang, C; Ji, W; Kong, D; Leng, X; Lu, L; Qin, Y; Sun, H; Wang, C; Wu, S; Zhang, L; Zhang, Z; Zhu, D | 1 |
| Fan, F; Hu, C; Huang, C; Kong, D; Leng, X; Lu, L; Qin, Y; Sun, H; Wang, C; Wang, H; Zhang, L; Zhang, Z; Zhu, D | 1 |
7 other study(ies) available for imiquimod and lipid a
| Article | Year |
|---|---|
Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Antibody Formation; Electroporation; Female; Hyaluronoglucosaminidase; Imiquimod; Immunization; Immunoglobulin G; Lipid A; Luciferases; Mice; Mice, Inbred BALB C; Ovalbumin; Plasmids; Vaccines, DNA | 2009 |
Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Delivery Systems; Female; Imiquimod; Immunity, Cellular; Immunity, Humoral; Lipid A; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nanostructures; Ovalbumin; Vaccines | 2013 |
Hyaluronic acid-supported combination of water insoluble immunostimulatory compounds for anti-cancer immunotherapy.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cancer Vaccines; Drug Carriers; Female; Hyaluronic Acid; Hydrogen Bonding; Imiquimod; Immunotherapy; Lipid A; Lymphoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Saponins; Solubility | 2017 |
The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cytokines; Female; Imiquimod; Immunization; Leishmania; Lipid A; Liposomes; Mice; Mice, Inbred BALB C; Particle Size; Solubility; Spleen | 2018 |
Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
Topics: Adjuvants, Immunologic; Animals; Antigens; Delayed-Action Preparations; Dendritic Cells; Imiquimod; Immunoglobulin G; Injections, Intradermal; Lipid A; Lymph Nodes; Mice, Inbred C57BL; Microinjections; Nanoparticles; Needles; Ovalbumin; Rats; Toll-Like Receptor 7; Vaccines | 2019 |
Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Topics: Animals; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Dendritic Cells; Drug Delivery Systems; Imiquimod; Immunotherapy; Lipid A; Mice; Nanoparticles; Neoplasms, Experimental; Toll-Like Receptors | 2019 |
Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination.
Topics: Animals; Antigens; Bone Marrow Cells; Cancer Vaccines; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Imiquimod; Interferon-gamma; Lipid A; Mannose; Mice; Mice, Inbred C57BL; Vaccination | 2019 |